⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALEC News
Alector, Inc. Common Stock
Form 8-K
sec.gov
ALEC
Form 8-K
sec.gov
ALEC
Treg Cell-Based Therapies Clinical Trial Pipeline Appears Robust With 29+ Key Pharma Companies Actively Working in the Domain | DelveInsight
globenewswire.com
RAPT
SANG
INCY
ABBV
ARCT
AMGN
CHKP
PFE
LLY
SCLX
SNY
UCB
BIIB
NVS
VTRS
BMY
ABSI
ALEC
GSK
IONS
CLNN
ANNX
MED
GAM
VRTX
EXC
BLRX
Form 8-K
sec.gov
ALEC
Form 8-K
sec.gov
ALEC
Alector Reports First Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
ALEC
Alector to Discontinue Phase 2 PROGRESS-AD Trial of Nivisnebart (AL101/GSK4527226) in Early Alzheimer’s Disease Following Interim Futility Analysis
globenewswire.com
ALEC
FASTPACE Expands C-PACE Partnership Network with Addition of SustainEnergyFinance, Utah's Green Bank
accessnewswire.com
ALEC
Form 8-K
sec.gov
ALEC
Alector Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
ALEC